Public Release: 

Winner of ESCEO-IOF Herbert Fleisch Medal announced

Charlotte Beaudart is awarded the ESCEO-IOF Herbert Fleisch Medal in recognition of outstanding research achievements in the field of bone and musculoskeletal diseases

International Osteoporosis Foundation

The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) have awarded the Herbert A. Fleisch ESCEO-IOF Medal to Dr Charlotte Beaudart, Adjunct Professor and researcher at the Department of Public Health, Epidemiology and Health Economics at the University of Liège, Belgium.

The Herbert A. Fleisch ESCEO-IOF Medal recognizes a researcher who has made outstanding and ground-breaking achievements in basic bone science. It is named after the late Professor Herbert Fleisch, a renowned researcher whose pioneering work contributed to the development of the field of scientific knowledge about metabolic bone diseases and their treatment. The Award was presented by IOF President John Kanis at the opening of the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases, which is taking place in Kraków, Poland from April 19-22, 2018.

ESCEO President Professor Jean-Yves Reginster stated: "It is a pleasure to extend this prestigious award to a young scientist with a proven track record for research and publication excellence. As an expert in advanced meta-analysis and through her outstanding contributions to ESCEO and EUGMS working groups on sarcopenia, Dr Beaudart has published influential papers which have significantly advanced our knowledge of epidemiology and health-related quality of life assessment in sarcopenia."

Dr Beaudart earned her PhD in public health sciences, epidemiology and health economics at the University of Liège, Belgium. She is Adjunct Professor, FNRS Fellow Assistant, and post-doctoral researcher at the Department of Public Health, Epidemiology and Health Economics at the University of Liège and is affiliated with the WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Ageing. She has also participated in a 6-month research study at the MRC Lifecourse Epidemiology Unit, University of Southampton, UK (2015-16). Dr Beaudart is a member of the Working Group 'Sarcopenia Guideline Development', the EUGMS Sarcopenia Special Interest Working Group, and the ESCEO Working Group on the Assessment of Quality of Life in Frailty and Sarcopenia, among other research interests and responsibilities. She is the recipient of several awards and grants, including distinctions awarded by the Belgian Bone Club as well as the 2014 IOF-Servier Young Investigator Research Grant. Dr Beaudart has published numerous papers as first author, is a reviewer for more than 25 scientific journals in the field, and is on the editorial board of Osteoporosis International, ACER Journal and BMC Musculoskeletal Disorders.


World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO Kraków 2018)

Held jointly by IOF and ESCEO, the Congress takes place in Kraków, Poland, from April 19-22, 2018.

WCO-IOF-ESCEO is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including sarcopenia and frailty. For complete information visit #OsteoCongress

About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 240 patient, medical and research societies in 99 locations, work together to make fracture prevention and healthy mobility a worldwide heath care priority. @iofbonehealth


The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.